Table 3.
Odds ratios (ORs) and 95% confidence intervals (CIs) associated with reproductive factors and inflammatory (IBC) and non-IBC
Variable | IBC (N= 267) |
Non-IBC (N=274) |
Control (N= 275) |
IBC vs. controls OR (95% CI)a |
Non-IBC vs. Controls OR (95% CI)a |
---|---|---|---|---|---|
Age at Menarche | |||||
<12 | 30 | 42 | 22 | 1.8 (0.9–3.6) | 2.1 (1.0–4.2) |
12–13 | 120 | 118 | 142 | 1.0 | 1.0 |
≥14 | 76 | 87 | 86 | 1.0 (0.7–1.5) | 1.2 (0.8–1.8) |
Unknown | 41 | 27 | 25 | ||
Number of livebirths | |||||
1–2 | 55 | 67 | 68 | 1.0 | 1.0 |
3–4 | 97 | 98 | 102 | 1.2 (0.8–1.9) | 0.9 (0.6–1.4) |
≥5 | 74 | 61 | 50 | 1.9 (1.1–3.3) | 1.1 (0.7–1.9) |
Nulliparous | 41 | 48 | 55 | 1.0 (0.6–1.6) | 0.9 (0.5–1.5) |
Age at first livebirth, years | |||||
< 20 | 58 | 54 | 45 | 1.0 | 1.0 |
20–24 | 72 | 89 | 76 | 0.7 (0.4–1.2) | 0.9 (0.6–1.5) |
≥25 | 95 | 81 | 98 | 0.7 (0.4–1.2) | 0.6 (0.4–1.1) |
Nulliparous | 41 | 48 | 55 | 0.6 (0.3–1.0) | 0.7 (0.4–1.3) |
Unknown | 1 | 2 | 1 | ||
Age at last livebirth, years | |||||
<30 | 53 | 71 | 72 | 1.0 | 1.0 |
30–34 | 72 | 72 | 80 | 1.2 (0.4–1.9) | 0.9 (0.6–1.4) |
≥35 | 100 | 81 | 66 | 2.1 (1.3–3.9) | 1.2 (0.8–2.0) |
Nulliparous | 41 | 48 | 55 | 1.1 (0.6–1.8) | 0.9 (0.6–1.6) |
Unknown | 1 | 2 | 1 | ||
Time since last live birth, years | |||||
≥10 | 148 | 171 | 164 | 1.0 | 1.0 |
5–9 | 29 | 31 | 30 | 1.4 (0.8–2.7) | 1.1 (0.6–1.9) |
3–4 | 20 | 10 | 13 | 2.7 (1.2–6.0) | 0.8 (0.3–2.1) |
0–2 | 28 | 12 | 11 | 4.5 (1.9–10.3) | 1.1 (0.5–2.9) |
Nulliparous | 41 | 48 | 55 | 1.0 (0.6–1.6) | 0.9 (0.6–1.5) |
Unknown | 1 | 2 | 1 | ||
Duration breast feeding (months) -among parous women who breast fed | |||||
0 – < 24 | 31 | 41 | 35 | 1.0 | 1.0 |
24 – < 60 | 68 | 85 | 76 | 1.1 (0.6–2.0) | 1.0 (0.6–1.7) |
60 – < 84 | 41 | 33 | 45 | 1.2 (0.6–2.4) | 0.7 (0.3–1.4) |
≥84 | 57 | 49 | 33 | 2.4 (1.2–4.9) | 1.3 (0.6–2.6) |
Unknown | 12 | 6 | 19 | ||
Never breast fed-parous | 17 | 12 | 12 | 1.8 (0.7–4.4) | 1.0 (0.4–2.7) |
Unknown whether breast fed | 1 | ||||
Nulliparous | 41 | 48 | 55 | 1.0 (0.5–1.8) | 0.9 (0.5–2.6) |
Duration exclusive breast feeding (months) among parous women who breast fed | |||||
0 – < 12 | 43 | 59 | 53 | 1.0 | 1.0 |
12 – < 24 | 65 | 72 | 74 | 1.4 (0.9–2.4) | 1.0 (0.6–1.7) |
24 – < 36 | 45 | 44 | 33 | 2.4 (1.3–4.4) | 1.4 (0.8–2.4) |
≥ 36 | 35 | 22 | 21 | 3.1 (1.6–6.1) | 1.1 (0.6–2.3) |
Unknown | 21 | 17 | 27 | ||
Never breast fed-parous | 17 | 12 | 12 | 2.2 (1.0–5.2) | 1.2 (0.5–2.8) |
Unknown whether breast fed | 1 | ||||
Nulliparous | 41 | 48 | 55 | 1.2 (0.7–2.1) | 1.0 (0.6–1.7) |
Ever had a breast problemb that prevented lactation, occurred during lactation or within 6 months after stopping lactation | |||||
No | 233 | 256 | 266 | 1.0 | 1.0 |
Yes | 34 | 18 | 9 | 4.4 (2.1–9.6) | 2.1 (0.9–4.8) |
Didn’t breast feed or stopped because of insufficient milk | |||||
No among parous | 184 | 192 | 180 | 1.0 | 1.0 |
Yes | 42 | 34 | 39 | 1.0 (0.6–1.7) | 0.8 (0.5–1.3) |
Nulliparous | 41 | 48 | 55 | 0.8 (0.5–1.2) | 0.9 (0.6–1.4) |
Ever tried to get pregnant for 2 years and/or visited a doctor for infertility | |||||
No | 229 | 247 | 241 | 1.0 | 1.0 |
Yes | 38 | 27 | 34 | 1.2 (0.7–1.9) | 0.8 (0.4–1.3) |
Years of oral contraceptive use (yrs) | |||||
No use | 156 | 164 | 186 | 1.0 | 1.0 |
< 5 | 45 | 46 | 28 | 2.0 (1.2–3.5) | 2.0 (1.3–2.4) |
5–9 | 31 | 20 | 18 | 2.3 (1.2–4.3) | 1.4 (0.7–2.9) |
≥10 | 35 | 44 | 43 | 1.1 (0.6–1.8) | 1.3 (0.8–2.1) |
Age at first oral contraceptive use | |||||
Never | 156 | 164 | 186 | 1.0 | 1.0 |
<25 | 40 | 55 | 35 | 1.5 (0.9–2.5) | 2.1 (1.2–3.4) |
25–34 | 52 | 37 | 48 | 1.4 (0.9–2.2) | 0.9 (0.6–1.5) |
≥ 35 | 19 | 18 | 6 | 4.1 (1.6–10.6) | 3.8 (1.4–9.9) |
Age last first oral contraceptive use | |||||
Never | 156 | 164 | 184 | 1.0 | 1.0 |
<30 | 24 | 26 | 17 | 1.8 (0.9–3.5) | 1.9 (1.0–3.7) |
30–39 | 43 | 34 | 35 | 1.6 (1.0–2.7) | 1.2 (0.7–2.0) |
≥ 40 | 44 | 50 | 37 | 1.6 (0.9–2.6) | 1.7 (1.1–2.8) |
Based on multiply imputed data; frequencies are before imputation; adjusted for matching variables: age categories (20–29, 30–34, 35–39, 40–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–84) as continuous, and location as shown in table 1.
Abscess, ulcer/sore, secretions, redness, swelling, pain, sore nipples, other